scutellarin has been researched along with Urinary Bladder Neoplasms in 1 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| An, JH; Liu, Q; Lv, WL; Song, XY | 1 |
1 other study(ies) available for scutellarin and Urinary Bladder Neoplasms
| Article | Year |
|---|---|
Scutellarin inhibits hypoxia-induced epithelial-mesenchymal transition in bladder cancer cells.
Topics: Animals; Antineoplastic Agents; Apigenin; Cell Hypoxia; Cell Line, Tumor; Cell Movement; Epithelial-Mesenchymal Transition; Glucuronates; Humans; Mice; Mice, Inbred BALB C; Mice, Nude; Urinary Bladder Neoplasms; Xenograft Model Antitumor Assays | 2019 |